Source:http://linkedlifedata.com/resource/pubmed/id/10796425
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-7-6
|
pubmed:abstractText |
Re-bleeding is an important cause of death and disability in people with aneurysmal subarachnoid haemorrhage. This is probably due to dissolution of the clot by natural fibrinolytic activity.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD001245
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
2000
|
pubmed:articleTitle |
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
|
pubmed:affiliation |
Department of Neurology, Academic Medical Centre (AMC), Meibergdreef 9, 1105 AZ Amsterdam, Netherlands, 1105 AZ. y.b.roos@amc.uva.nl
|
pubmed:publicationType |
Journal Article,
Review
|